Compugen CGEN
NASDAQ CGEN
$2.34 -0.04 (-1.68%)
At close: Oct 1, 2026 · 4:00 PM EDT

Compugen (CGEN) Cash from Financing Activities (2009 - 2010)

Updated

Compugen's Cash from Financing Activities was $10.6 million in FY2025, compared with $554,000 in FY2024.

Analysis

Compugen (CGEN) Cash from Financing Activities (2009 - 2010) Analysis & Trends

From FY2009 onward, Compugen has reported Cash from Financing Activities for 17 years.

  • Cash from Financing Activities shows a five-year compound annual growth rate of -37.2% (FY2020 to FY2025).
  • The FY2025 figure marks the highest annual Cash from Financing Activities since FY2021.
  • Per Business Quant data, Cash from Financing Activities in earlier years was $554,000 in FY2024 (-82.0%), $3.08 million in FY2023 (+772.8%), $353,000 in FY2022 (-97.9%) and $16.84 million in FY2021 (-84.5%).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Financing (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn -8.78 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn -5.05 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 1.76 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn -2.02 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn -47.00 Mn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn -1.48 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 2.34 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn -3.66 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn -426.70 Mn
10 Compugen 225.04 Mn -148.05 Mn -92,000.00 -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2010 890,000.00
Sep 30, 2010 85,000.00
Dec 31, 2009 12.10 Mn
API Access

Compugen Cash from Financing Activities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=cash-from-financing-activities&ticker=CGEN&period=max&api_key=YOUR_API_KEY